Fig. 2
From: The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors
A 2 [68Ga]Ga-DOTA-TATE PET MIP (a, b) images in two female patients, 42-year and 49-year-old, with ectopic ACTH secreting Cushing syndrome due to metastatic neuroendocrine tumors. Primary tumor sites in both patients were identified by [68Ga]Ga-DOTA-TATE as shown by focal intense uptake (SUVmax 25.3 and 35.5) at small bowel (filled arrow) and head of pancreas (dashed arrow). Both patients subsequently underwent for somatostatin receptor radionuclide therapy